Enterprise Financial Services Corp Gilead Sciences, Inc. Transaction History

Enterprise Financial Services Corp

$170 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $731,522 - $830,291	-11,275 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $708,105 - $763,966	10,461 Added 1285.14%	11,275 $788,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $2,157 - $2,357	-34 Reduced 4.01%	814 $56,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $3,300 - $3,765	-55 Reduced 6.09%	848 $55,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $20,790 - $23,689	-367 Reduced 28.9%	903 $53,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $45,146 - $56,764	-727 Reduced 36.4%	1,270 $80,000
Q2 2020 Aug 04, 2020	BUY	$72.34 - $84.0 $4,268 - $4,956	59 Added 3.04%	1,997 $153,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $47,348 - $60,646	756 Added 63.96%	1,938 $145,000
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $24,894 - $27,383	404 Added 51.93%	1,182 $77,000
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $13,627 - $15,042	-218 Reduced 21.89%	778 $49,000
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $23,819 - $26,711	385 Added 63.01%	996 $66,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $6,878 - $7,705	110 Added 21.96%	611 $39,000
Q4 2018 Jan 25, 2019	SELL	$60.54 - $79.0 $26,455 - $34,523	-437 Reduced 46.59%	501 $31,000
Q3 2018 Oct 26, 2018	BUY	$71.28 - $78.92 $13,685 - $15,152	192 Added 25.74%	938 $72,000
Q2 2018 Jul 27, 2018	BUY	$64.88 - $75.68 $5,255 - $6,130	81 Added 12.18%	746 $53,000
Q1 2018 Apr 27, 2018	BUY	$72.84 - $88.8 $2,695 - $3,285	37 Added 5.89%	665 $50,000
Q4 2017 Jan 26, 2018	SELL	$71.15 - $83.52 $14,230 - $16,704	-200 Reduced 24.15%	628 $45,000
Q3 2017 Oct 27, 2017	BUY	$72.11 - $85.47 $59,707 - $70,769	828	828 $67,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Financial Services Corp with notifications on news.

Account